investor FAQ

Where is Maze Therapeutics’ corporate headquarters?
Maze is headquartered in South San Francisco, CA.
When did Maze begin operations?

Maze commenced operations in 2018.

When did Maze go public?

Maze’s initial public offering (IPO) occurred on January 31, 2025.

When is Maze’s fiscal year-end?

Maze’s fiscal year ends on December 31.

How is Maze’s stock traded?

Maze is traded on the Nasdaq Global Market under the ticker symbol MAZE, and its CUSIP number is 578784 100.

Who is Maze’s transfer agent?

Maze’s transfer agent is: 

Equiniti Trust Company, LLC
48 Wall St., Floor 23, New York, NY 10005
Website: equiniti.com/us
Email: HelpAST@equiniti.com
Phone (U.S.): (800) 937-5449
Phone (International): (718) 921-8124

Who are Maze’s independent auditors?

Ernst & Young LLP

Who is Maze’s legal counsel?

Fenwick & West LLP

Where can I get the latest corporate news releases?

Maze’s press releases can be viewed here.

How can I view documents Maze has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?

Maze’s SEC filings can be viewed here.

Whom should I contact if I have further questions?

Additional queries can be directed to Amy Bachrodt at abachrodt@mazetx.com.

email alerts

To opt-in for investor email alerts, please select at least one alert option and enter your email address in the field below. After submitting your request, an activation email will be sent to the address provided. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. If you would like to opt out of email alerts, you can unsubscribe here. 

investor contacts

Maze Therapeutics:
Amy Bachrodt

abachrodt@mazetx.com

 

Dan Budwick, 1AB

dan@1abmedia.com